Literature DB >> 17699177

Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance.

David Barnett1, Seren Phillips, Carole Longson.   

Abstract

This NICE technology appraisal guidance on cardiac resynchronisation therapy provides additional treatment options for some of the groups of people covered in the earlier guidance on implantable cardioverter defibrillators.

Entities:  

Mesh：

Year:  2007        PMID： 17699177      PMCID： PMC1955017          DOI： 10.1136/hrt.2007.127563

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  2 in total

1.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

2.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245
  2 in total
  10 in total

Review 1.  Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

Authors:  Francisco Leyva; Paul W X Foley
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

2.  New guidelines for cardiac resynchronisation therapy: simplicity or complexity for the doctor?

Authors:  C Leclercq
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

3.  The impact of age on clinical outcomes following cardiac resynchronisation therapy.

Authors:  K Guha; D Konstantinou; L Mantziari; B N Modi; B Chandrasekaran; Z Khalique; T McDonagh; R Sharma
Journal:  J Interv Card Electrophysiol       Date:  2013-11-29       Impact factor: 1.900

4.  NICE Methodology for Technology Appraisals: cutting edge or tried and trusted?

Authors:  Louise Longworth; Carole Longson
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy.

Authors:  F Leyva; P W X Foley; B Stegemann; J A Ward; L L Ng; M P Frenneaux; F Regoli; R E A Smith; A Auricchio
Journal:  Heart       Date:  2009-07-09       Impact factor: 5.994

Review 6.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

7.  Initial experience of a cohort of patients with hypertrophic cardiomyopathy undergoing biventricular pacing.

Authors:  Christopher A Rinaldi; Senthil Kirubakaran; Clifford A Bucknall; Julian Bostock; Jaswinder S Gill
Journal:  Indian Pacing Electrophysiol J       Date:  2011-02-08

8.  Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance.

Authors:  Francisco Leyva; Paul W X Foley; Shajil Chalil; Karim Ratib; Russell E A Smith; Frits Prinzen; Angelo Auricchio
Journal:  J Cardiovasc Magn Reson       Date:  2011-06-13       Impact factor: 5.364

9.  Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model.

Authors:  Mattias Neyt; Serge Stroobandt; Caroline Obyn; Cécile Camberlin; Stephan Devriese; Chris De Laet; Hans Van Brabandt
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

Review 10.  What is treatment success in cardiac resynchronization therapy?

Authors:  Paul W X Foley; Francisco Leyva; Michael P Frenneaux
Journal:  Europace       Date:  2009-11       Impact factor: 5.214
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.